Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs BALAXI PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS BALAXI PHARMA NOVARTIS/
BALAXI PHARMA
 
P/E (TTM) x 26.6 -103.5 - View Chart
P/BV x 3.3 3.1 104.5% View Chart
Dividend Yield % 4.6 0.0 -  

Financials

 NOVARTIS   BALAXI PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-23
BALAXI PHARMA
Mar-23
NOVARTIS/
BALAXI PHARMA
5-Yr Chart
Click to enlarge
High Rs763670 113.9%   
Low Rs554490 113.0%   
Sales per share (Unadj.) Rs153.4330.5 46.4%  
Earnings per share (Unadj.) Rs41.945.2 92.7%  
Cash flow per share (Unadj.) Rs44.346.9 94.6%  
Dividends per share (Unadj.) Rs47.500-  
Avg Dividend yield %7.20-  
Book value per share (Unadj.) Rs314.2169.5 185.3%  
Shares outstanding (eoy) m24.6910.18 242.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.31.8 244.6%   
Avg P/E ratio x15.712.8 122.5%  
P/CF ratio (eoy) x14.912.4 120.1%  
Price / Book Value ratio x2.13.4 61.3%  
Dividend payout %113.50-   
Avg Mkt Cap Rs m16,2625,905 275.4%   
No. of employees `000NANA-   
Total wages/salary Rs m356290 123.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,7873,364 112.6%  
Other income Rs m58126 2,203.6%   
Total revenues Rs m4,3693,391 128.8%   
Gross profit Rs m651574 113.4%  
Depreciation Rs m6118 345.7%   
Interest Rs m1814 127.1%   
Profit before tax Rs m1,154569 202.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m120110 109.7%   
Profit after tax Rs m1,034460 224.9%  
Gross profit margin %17.217.1 100.7%  
Effective tax rate %10.419.3 54.1%   
Net profit margin %27.313.7 199.8%  
BALANCE SHEET DATA
Current assets Rs m7,8611,935 406.2%   
Current liabilities Rs m2,683531 504.9%   
Net working cap to sales %136.741.7 327.7%  
Current ratio x2.93.6 80.5%  
Inventory Days Days1,2012 57,689.4%  
Debtors Days Days35567 6.1%  
Net fixed assets Rs m12,656462 2,741.9%   
Share capital Rs m123102 121.2%   
"Free" reserves Rs m7,6341,624 470.0%   
Net worth Rs m7,7571,726 449.5%   
Long term debt Rs m09 0.0%   
Total assets Rs m20,5172,397 856.1%  
Interest coverage x66.942.3 158.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.21.4 13.2%   
Return on assets %5.119.8 25.9%  
Return on equity %13.326.6 50.0%  
Return on capital %15.133.6 44.9%  
Exports to sales %2.10-   
Imports to sales %00-   
Exports (fob) Rs m80NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m80802 10.0%   
Fx outflow Rs m94640 2,376.0%   
Net fx Rs m-866763 -113.5%   
CASH FLOW
From Operations Rs m44861 737.4%  
From Investments Rs m-1,533-106 1,450.5%  
From Financial Activity Rs m-305255 -119.5%  
Net Cashflow Rs m-1,389210 -660.9%  

Share Holding

Indian Promoters % 0.0 71.2 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.7 18.6 3.8%  
FIIs % 0.2 18.6 1.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 28.8 101.9%  
Shareholders   43,128 5,045 854.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ADANI ENTERPRISES    REDINGTON    MMTC    SIRCA PAINTS INDIA    


More on Novartis vs BALAXI PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Novartis vs BALAXI PHARMA Share Price Performance

Period Novartis BALAXI PHARMA S&P BSE HEALTHCARE
1-Day -0.22% 1.44% 1.18%
1-Month 7.46% -19.69% -0.75%
1-Year 81.59% -6.71% 61.82%
3-Year CAGR 23.12% -7.28% 18.16%
5-Year CAGR 8.47% -4.43% 19.79%

* Compound Annual Growth Rate

Here are more details on the Novartis share price and the BALAXI PHARMA share price.

Moving on to shareholding structures...

The promoters of Novartis hold a 70.7% stake in the company. In case of BALAXI PHARMA the stake stands at 71.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of BALAXI PHARMA.

Finally, a word on dividends...

In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.

BALAXI PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Novartis, and the dividend history of BALAXI PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.